Fisher & Paykel Healthcare renews key US distribution deal

Healthcare products maker Fisher & Paykel Healthcare (FPH) has renewed a key distribution deal that gets its products into US hospitals.

Renewal of a 25-year-old agreement continues to give global medical tech giant CareFusion exclusive distribution rights for FPH’s respiratory care products in US hospital market.

CareFusion will continue to be the US distributor of FPH’s portfolio of respiratory consumable products that help with the treatment of obstructive sleep apnea.

CareFusion has its own respiratory consumables business under the AirLife brand.

Shares in FPH last traded at $2.11, having fetched between $2.09 and $3.19 in the last year.

This article is tagged with the following keywords. Find out more about My Tags

Comment & Question

Commenter icon key: Subscriber Verified

Post New comment or question

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

NZ Market Snapshot

Forex

Sym Price Change
USD 0.7808 -0.0042 -0.54%
AUD 0.9150 0.0015 0.16%
EUR 0.6259 -0.0066 -1.04%
GBP 0.4971 -0.0038 -0.76%
HKD 6.0552 -0.0340 -0.56%
JPY 92.0630 -1.0800 -1.16%

Commods

Commodity Price Change Time
Gold Index 1195.7 -4.340 2014-11-24T00:
Oil Brent 80.2 1.630 2014-11-24T00:
Oil Nymex 75.8 -0.780 2014-11-24T00:
Silver Index 16.4 -0.020 2014-11-24T00:

Indices

Symbol Open High Last %
NZX 50 5442.7 5459.9 5442.7 0.15%
NASDAQ 4762.4 4774.5 4754.9 0.07%
DAX 9790.0 9921.5 9785.5 0.77%
DJI 17819.1 17854.7 17817.9 -0.02%
FTSE 6729.8 6750.9 6729.8 0.02%
HKSE 23841.2 23935.1 23893.1 -0.21%
NI225 17490.4 17490.4 17357.5 0.29%